New concepts of glucose-induced insulin secretion in the development of type 2 diabetes: clinical implications

The prevalence of type 2 diabetes is increasing dramatically, and the pathogenesis of the disease has been studied extensively in recent years. Of particular interest, incretins are reported to cause changes in insulin secretion that affect the natural development of the disease. The emergence of ne...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ivan Ivanovich Dedov, Olga Michailovna Smirnova, Kononenko Vladimirovna Irina
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2015
Materias:
Acceso en línea:https://doaj.org/article/5136acef822b45b6a6dddfc208a9d30d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5136acef822b45b6a6dddfc208a9d30d
record_format dspace
spelling oai:doaj.org-article:5136acef822b45b6a6dddfc208a9d30d2021-11-14T09:00:19ZNew concepts of glucose-induced insulin secretion in the development of type 2 diabetes: clinical implications2072-03512072-037810.14341/DM2015323-31https://doaj.org/article/5136acef822b45b6a6dddfc208a9d30d2015-10-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/7125https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378The prevalence of type 2 diabetes is increasing dramatically, and the pathogenesis of the disease has been studied extensively in recent years. Of particular interest, incretins are reported to cause changes in insulin secretion that affect the natural development of the disease. The emergence of new drugs that act via the incretin axis have led many clinicians to consider their place in clinical practice.Ivan Ivanovich DedovOlga Michailovna SmirnovaKononenko Vladimirovna IrinaEndocrinology Research Centrearticlepathogenesisthe insulin secretionsignaling pathwaysdrugs actionNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 18, Iss 3, Pp 23-31 (2015)
institution DOAJ
collection DOAJ
language EN
RU
topic pathogenesis
the insulin secretion
signaling pathways
drugs action
Nutritional diseases. Deficiency diseases
RC620-627
spellingShingle pathogenesis
the insulin secretion
signaling pathways
drugs action
Nutritional diseases. Deficiency diseases
RC620-627
Ivan Ivanovich Dedov
Olga Michailovna Smirnova
Kononenko Vladimirovna Irina
New concepts of glucose-induced insulin secretion in the development of type 2 diabetes: clinical implications
description The prevalence of type 2 diabetes is increasing dramatically, and the pathogenesis of the disease has been studied extensively in recent years. Of particular interest, incretins are reported to cause changes in insulin secretion that affect the natural development of the disease. The emergence of new drugs that act via the incretin axis have led many clinicians to consider their place in clinical practice.
format article
author Ivan Ivanovich Dedov
Olga Michailovna Smirnova
Kononenko Vladimirovna Irina
author_facet Ivan Ivanovich Dedov
Olga Michailovna Smirnova
Kononenko Vladimirovna Irina
author_sort Ivan Ivanovich Dedov
title New concepts of glucose-induced insulin secretion in the development of type 2 diabetes: clinical implications
title_short New concepts of glucose-induced insulin secretion in the development of type 2 diabetes: clinical implications
title_full New concepts of glucose-induced insulin secretion in the development of type 2 diabetes: clinical implications
title_fullStr New concepts of glucose-induced insulin secretion in the development of type 2 diabetes: clinical implications
title_full_unstemmed New concepts of glucose-induced insulin secretion in the development of type 2 diabetes: clinical implications
title_sort new concepts of glucose-induced insulin secretion in the development of type 2 diabetes: clinical implications
publisher Endocrinology Research Centre
publishDate 2015
url https://doaj.org/article/5136acef822b45b6a6dddfc208a9d30d
work_keys_str_mv AT ivanivanovichdedov newconceptsofglucoseinducedinsulinsecretioninthedevelopmentoftype2diabetesclinicalimplications
AT olgamichailovnasmirnova newconceptsofglucoseinducedinsulinsecretioninthedevelopmentoftype2diabetesclinicalimplications
AT kononenkovladimirovnairina newconceptsofglucoseinducedinsulinsecretioninthedevelopmentoftype2diabetesclinicalimplications
_version_ 1718429526802825216